actual strategy improv current therapy advance prostate cancer involve target gene active androgen withdraw either delay prevent emerge castrationrefractori phenotype howe often italic sever physiology process longterm inhibit survive protein might accompany cytotox effect avoid problem alter therapeutic reli identify use compound disrupt specify proteinprotein interact involve specify interact chaperone protein sp init factor if lead protect synthesis process enhance cell stress induce castro chemotherapy thu work aim identify site hspeif complex ii interfere elev assoc meghan castrationresist progress combine experiment model technique prove interact termini part preference phosphorus also observe loss increase chemoand hormonesensit order find potent inhibitor bet assay molecular simply identify phenazin derive compound abl office thereby inhibit viable increase death chem model vitro vivo 